-
Most Popular

Biotech Stocks
Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

3 Promising Biotech Stocks for the Long-Term: August 2024
Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few.

The 3 Best Healthcare Stocks to Buy in August 2024
These are the best healthcare stocks that could bring in massive returns to the investors in the future. Do not miss out on this opportunity.
Recent Biotech Stocks Articles
Why Is Gamida Cell (GMDA) Stock Down 82% Today?
Gamida Cell stock is falling on Wednesday with heavy trading of GMDA shares after the company announced plans to go private.
Why Is iBio (IBIO) Stock Up 125% Today?
IBIO stock is soaring after the firm announced that it would launch a partnership based on AI and obesity treatments.
3 Strong Buy Biotech Stocks to Add to Your Q2 Must-Watch List
Don’t miss out on these three strong buy biotech stocks that are leaders to add to your portfolio for Q2 this year.
Why Is Viking Therapeutics (VKTX) Stock Up 24% Today?
Viking Therapeutics stock is rising higher on Tuesday as investors in VNKTX shares react to positive Phase 1 clinical trial results.
Why Is NeuBase Therapeutics (NBSE) Stock Down 58% Today?
NeuBase Therapeutics stock is down on Tuesday as NBSE investors react to details concerning an upcoming special shareholder meeting.
Why Is Stoke Therapeutics (STOK) Stock Up 99% Today?
Stoke Therapeutics stock is up on Tuesday as STOK shares see heavy trading alongside recent positive clinical trial data.
Why Is Landos Biopharma (LABP) Stock Up 168% Today?
Landos Biopharma stock is up on Monday as LABP investors learn about a massive acquisition deal with AbbVie that values it at $137.5 million.
Why Is Ocugen (OCGN) Stock Up 20% Today?
Ocugen stock is heading higher on Friday as investors in OCGN shares react to a dismissed class action lawsuit against the company.
Why Is Sintx Technologies (SINT) Stock Down 31% Today?
Sintx Technologies stock is falling on Friday as investors prepare for more details about a proposed public offering of SINT Shares.